353 related articles for article (PubMed ID: 33708844)
1. Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes.
Geng JH; Zhang YZ; Li YH; Li S; Wang L; Wang ZL; Zhu XG; Bu ZD; Li ZY; Su XQ; Cai Y; Wu AW; Wang WH
Ann Transl Med; 2021 Feb; 9(3):217. PubMed ID: 33708844
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node.
Li S; Zhang Y; Yu Y; Zhu X; Geng J; Teng H; Wang Z; Sun T; Wang L; Wang H; Li Y; Wu A; Cai Y; Wang W
Front Oncol; 2020; 10():627572. PubMed ID: 33692945
[TBL] [Abstract][Full Text] [Related]
3. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node.
Li S; Geng J; Wang L; Teng H; Wang Z; Zhu X; Zhang Y; Wang H; Li Y; Cai Y; Wu A; Wang W
Cancer Manag Res; 2021; 13():537-546. PubMed ID: 33519233
[TBL] [Abstract][Full Text] [Related]
4. The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes.
Meldolesi E; Chiloiro G; Giannini R; Menghi R; Persiani R; Corvari B; Coco C; Manfrida S; Ratto C; De Luca V; Sofo L; Reina S; Crucitti A; Masiello V; Dinapoli N; Valentini V; Gambacorta MA
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406415
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
6. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
7. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
[TBL] [Abstract][Full Text] [Related]
8. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
9. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
10. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.
Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405
[TBL] [Abstract][Full Text] [Related]
11. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
12. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
13. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
14. Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?
Otero de Pablos J; Mayol J
Front Surg; 2019; 6():79. PubMed ID: 32010707
[TBL] [Abstract][Full Text] [Related]
15. Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study.
Lupattelli M; Matrone F; Gambacorta MA; Osti M; Macchia G; Palazzari E; Nicosia L; Navarria F; Chiloiro G; Valentini V; Aristei C; De Paoli A
Radiat Oncol; 2017 Aug; 12(1):139. PubMed ID: 28830475
[TBL] [Abstract][Full Text] [Related]
16. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial.
Zhang W; Zhou H; Jiang J; Zhu Y; Zou S; Jiang L; Tang Y; Liang J; Sun Y; Jiang Z; Qu W; Li Y; Zhou A
BMC Cancer; 2023 Jun; 23(1):592. PubMed ID: 37370032
[TBL] [Abstract][Full Text] [Related]
18. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Extended Dissection of Lateral Pelvic Lymph Nodes During Laparoscopic Total Mesorectal Excision in Patients with Locally Advanced Lower Rectal Cancer: A Single-Center Pilot Study After Neoadjuvant Chemotherapy.
Aisu Y; Kato S; Kadokawa Y; Yasukawa D; Kimura Y; Takamatsu Y; Kitano T; Hori T
Med Sci Monit; 2018 Jun; 24():3966-3977. PubMed ID: 29890514
[TBL] [Abstract][Full Text] [Related]
20. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?
Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ
Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]